Invacare (IVC +31.1%) is up in early trade on the heels of its Q3 report released after the close yesterday. Highlights:
Sales down 4% to $235.8M, operating income up 145% to $2.4M.
Non-GAAP EBITDA up 773% to $9.6M, free cash flow up 592% to $12.3M.
Loss/share: ($0.24) (+33%).
2019 and 2020 guidance reaffirmed.
Previously: Invacare EPS beats by $0.05, misses on revenue (Nov. 6)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.